A5051951127- Renal Transplantation Outcomes and Treatments
- Renal Diseases and Glomerulopathies
- Organ Transplantation Techniques and Outcomes
- Cytomegalovirus and herpesvirus research
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Complement system in diseases
- Systemic Lupus Erythematosus Research
- Organ Donation and Transplantation
- Parvovirus B19 Infection Studies
- Pregnancy and Medication Impact
- Pneumocystis jirovecii pneumonia detection and treatment
- Dialysis and Renal Disease Management
- Reproductive System and Pregnancy
- Chronic Kidney Disease and Diabetes
- COVID-19 Clinical Research Studies
- Renal and Vascular Pathologies
- Transplantation: Methods and Outcomes
- SARS-CoV-2 and COVID-19 Research
- Polyomavirus and related diseases
- Erythropoietin and Anemia Treatment
- Neurological Complications and Syndromes
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Viral-associated cancers and disorders
- Antifungal resistance and susceptibility
Université de Nîmes
2020-2024
Université de Montpellier
2020-2024
Centre Hospitalier Universitaire de Nîmes
2020-2024
Shahid Beheshti University of Medical Sciences
2014-2023
Hôpital Tenon
2020
Sorbonne Université
2020
Assistance Publique – Hôpitaux de Paris
2020
Urmia University
2007-2009
Urmia University of Medical Sciences
2007-2009
Shahid Beheshti University
2009
Abstract Background Thymoglobulin is used effectively as an induction agent in kidney transplantation, but there no consensus on the optimal dose. In order to delineate safest effective dose, open‐labeled randomized clinical trial was designed. Methods this study, 90 adult transplant recipients ( KTR ) were before transplantation three groups receive thymoglobulin: Arm A (4.5 mg/kg 3 days), B single bolus dose), and C (6 days). Renal function, infections, rate of readmissions evaluated...
Acute tubular necrosis (ATN), a frequent histopathological feature in the early post-renal transplant biopsy, affects long-term graft function. Appropriate markers to identify patients at risk of no or incomplete recovery after delayed function are lacking. In this study, we first included 41 renal whose biopsy for cause during month transplantation showed ATN lesions. Using partial microvasculature endothelial (fascin, vimentin) and epithelial (vimentin) mesenchymal transition markers,...